about
How does fingolimod (gilenya(®)) fit in the treatment algorithm for highly active relapsing-remitting multiple sclerosis?Genetic aspects of vitamin D receptor and metabolism in relation to the risk of multiple sclerosis.Impaired baroreflex sensitivity predicts outcome of acute intracerebral hemorrhage.Recommendations for the use of prolonged-release fampridine in patients with multiple sclerosis (MS).Baroreflex sensitivity to predict malignant middle cerebral artery infarction.Challenges with advanced therapy medicinal products and how to meet them.Subacute perihematomal edema in intracerebral hemorrhage is associated with impaired blood pressure regulation.Spectrum of DHCR7 mutations in Slovak patients with Smith-Lemli-Opitz syndrome and detection of common mutations by PCR-based assays.Are blood platelets involved in the pathogenesis of ischemic brain edema in gerbils?Effect of long-term administration of stobadine on exploratory behaviour and on striatal levels of dopamine and serotonin in rats and their offspring.Autonomic effects of intraventricular extension in intracerebral hemorrhage.Impaired baroreceptor reflex sensitivity in acute stroke is associated with insular involvement, but not with carotid atherosclerosis.The effect of betaadrenoceptor blocking drugs on malondialdehyde production in the rat plateletsThe effect of beta adrenoceptor blocking drugs on the integrity of rat platelets as measured by 51Cr liberationON the serotonin liberation from rat platelets due to betaadrenoceptor blocking drugsInhibitory effect of stobadine on FMLP-induced chemiluminescence in human whole blood and isolated polymorphonuclear leukocytesAdult onset cerebral form of X-linked adrenoleukodystrophy with dementia of frontal lobe type with new L160P mutation in ABCD1 geneBaroreflex sensitivity in patients with type I diabetes mellitusAutonomic shift and increased susceptibility to infections after acute intracerebral hemorrhageStroke care in Central Eastern Europe: current problems and call for action
P50
Q36806028-AE8C9081-9630-4C5C-B1CB-EB342E8189B5Q38143327-BDBD5E5A-69BE-4DD3-8A15-1B9B624C47A2Q40040850-D13C5023-DC30-4EC0-840E-5E6B5917828DQ44483210-4AF3D09B-41C9-4A8C-BE63-754BDE2A8888Q45326228-4DA72629-BD2E-4A7A-882A-F21F78589E0DQ45857265-6D69937F-B6A1-4CE9-938B-73C0D1C0E078Q46018961-38ADBA0A-B138-4B99-866E-EBC4E722975FQ46038676-5A8A71B8-CE98-4D86-A0D5-C7CA10440F53Q48092028-806EFA07-CAA3-40E1-B71B-9F47606EF611Q48772784-92249E2C-8587-4A8B-8395-5BA3C34642ABQ48859464-D2F1E498-8B0A-4AAD-8A7A-9F1F9833A4B7Q53377181-B4912C4C-1F00-4240-852E-7BF0BFD3492AQ72490876-683B85B6-C349-463C-B17A-20C3F9E95C5DQ72507017-971287D0-39D9-4F56-BEDB-F1B9E4770278Q72542751-982B47A2-6B52-4E83-824D-8B85BBFFB8D1Q80001917-59A75945-92DB-47F5-AA6E-93C820F8278EQ80698768-F1FA58E1-69BD-47D0-B1CC-292FE27122E3Q82243005-7BACC619-1713-4AFC-9DC8-2AF461F95EDFQ83584854-20F64BC8-0F8B-4AC3-AF5E-EE3BD674645BQ84968794-5B4D6D38-3884-4779-A061-521DEBCEAC77
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Peter Turcani
@ast
Peter Turcani
@en
Peter Turcani
@es
Peter Turcani
@nl
Peter Turcani
@sl
type
label
Peter Turcani
@ast
Peter Turcani
@en
Peter Turcani
@es
Peter Turcani
@nl
Peter Turcani
@sl
prefLabel
Peter Turcani
@ast
Peter Turcani
@en
Peter Turcani
@es
Peter Turcani
@nl
Peter Turcani
@sl
P106
P21
P31
P496
0000-0002-4868-6836